Zoetis price to book ratio ZTS

Market value divided by the book value of the company's net assets, since 2013.

Today, Oct 23, 2026: 10.6×
10-year median: 18.1×
Against its 10-year history: 7th; percentile: 0 is its lowest day, 100 its highest
10-year range: 9.1× to 26.4×
Peer median: 5.5×

Zoetis' price to book ratio is 10.6× as of Oct 23, 2026.

That is below its ten-year median of 18.1×, lower than on 93% of days in the last ten years.

Over that time it ranged from 9.1× in Oct 2026 to 26.4× in Oct 2020.

The median for 10 healthcare stocks of a similar size is 5.5×.

Price to book ratio over time

median 18.1×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	10.6×	9.1×	16.6×
2025	10.3×	9.7×	16.3×
2024	14.2×	13.4×	18.1×
2023	17.8×	14.7×	19.5×
2022	14.6×	13.4×	21.3×
2021	24.7×	18.4×	24.7×
2020	21.8×	17.7×	26.4×
2019	23.7×	19.2×	25.4×
2018	19.2×	17.7×	23.4×
2017	17.6×	16.7×	19.3×
2016	16.7×	15.3×	22.6×
2015	19.4×	15.7×	20.5×
2014	16.2×	13.4×	19.3×
2013	19.4×	18.2×	23.9×

Against its peers

Companies in Healthcare nearest Zoetis' size, closest first, today.

Company	Price to book ratio
ZTSZoetis	10.6×
MTDMettler-Toledo International	n/m
CNCCentene	1.5×
GEHCGE HealthCare Technologies	2.9×
RMDResMed	5.5×
RPRXRoyalty Pharma	5.4×
BIIBBiogen	2.0×
ALNYAlnylam Pharmaceuticals	22.1×
DXCMDexCom	11.2×
WSTWest Pharmaceutical Services	9.2×
ILMNIllumina	14.3×
Peer median	5.5×

What the price to book ratio tells you

Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.

Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.

More on Zoetis

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.